Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Personally speaking, I've never considered the true value of a PR being related to immediate share price movement.
On January 6th when CLWD was trading in the .0070 range and then spiked to an intraday high of .1830 on January 13th (around a 2500% gain) only one PR had been released and that was in reference to the AI.Advertising venture, which in retrospect, a company move that could have been anticipated since back in October 2020 they released a PR in regard to adding AI to their existing tech stack.
What a PR and disclosures released by the company allows is for not only me but other financial entities to get a glimpse through a window that displays what direction the company is taking and the future prospects of that stated course.
Financial institutions have exceptionally skilled technicians that have a vast array of technical resources available to them that provides incredibly refined analysis of data for each and every industry which leads to the uncovering of companies with the greatest potential at all levels of the investment markets. Their stature and position lends itself to more detailed information being provided in terms of company developments. They're the source of finance whether it's through "securities purchase agreements" or taking a large holdings position because they're the catalyst that moves share prices significantly and have the most impact in increasing the company's value through stock price appreciation. There's a reason why companies on the major exchanges have the brief customary conference call every quarter directly after the earnings are announced for the general retail investor that touches lightly on results and then after have an extended session with current and potential financial institutional investors.
In CLWD's case the last two PR's has definitely peaked interest in the potential of market share that can be gained and all the financial ramifications companies are going to be facing due to the directions being taken pointed out in the news releases. You can bet institutional technical analysts are busy researching the scope of the impact and whether the CLWD directional solution is really significant to the point of gaining real traction within the industry.
The fact a financial institution has already taken a major stake through share ownership is a good sign, as well as a CTO taking a 40M share position, leads one to believe there's some credence to what CLWD has developed.
When you factor in the parabolic moves OTC stocks can take based on environmental impacts. CLWD may be the best positioned one out of the group. Their O/S count is low compared to the multi-billions by most OTC companies but yet large enough to create plenty of liquidity which institutional investors prefer. Based on the way CLWD currently trades is a good indicator the bulk of the float is currently held by deeper pocket sources and the fact one has a 240M share stake which is a quarter of the O/S totals is a clear indicator when the powers that be are ready to move the share price due to the ownership dynamic it will naturally equate to a more emphatic move to the upside.
With overall economic recovery taking hold reflective in exceptional 4th Qtr earnings reports in a lot of industries coupled with stimulus bill money distributions the world of commerce is about to witness immediate impactful growth that will last throughout 2021 and investors are going to witness a real favorable impact to stock prices. I can't think of a better equity to be invested in as this unfolds.
Excellent points of reference my friend, let me compliment this by saying with economic recovery firmly in place now reflective in overall 4th Qtr earning reports and stimulus package monies being distributed you're going to see an incredible increase in spending by both consumer and corporate over the course of 2021. Services like what BYOC offers become even more invaluable and heavily recruited in order to take full advantage of the surge in commerce as the economy reaches its full stride.
With BYOC investing in their existing software platform with SaaS and cloud based solutions which will bestow more effective and refined data analysis offerings providing BYOC with an incredible avenue to add additional clients to their already impressive lists, consequently recognizing significant revenue growth moving forward.
Financial institutions have incredible skilled staffs working for them that are exceptionally good at finding undervalued companies at all market levels. When they take into consideration the emphatic uptick in commerce in the coming months factored in with an already excepted and vital service being provided recognized by an impressive company client list... well they see a lot of upside in this particular equity in that it will receive an enormous amount of investor interest which intensifies volume providing plenty of liquidity which the instruments of influence just love.
Needless to say the potential parabolic movement to the upside for this particular holding is definitely in the works.
BYOC organic revenue growth moving forward:
BYOC has already accomplished the biggest hurdle in that it has established itself a solid clientele base.
The 2M revenue figure you inquire about is already supported by the number of entities BYOC has contracted. As economic recovery improves companies/corporations will start allocating additional monies into these types of areas of service BYOC provides in order to help improve upon their level of functionality enhancing their bottom line growth.
I get the impression based on the A/S increase and the raising of additional capital monies through the selling of shares via the open market which has been evident over the last couple trading days just happens to be in direct correlation to their stated plan to further automate their internal software processes.
One of their stated goals was to increase their suite of offerings which is exactly what a company who has such an impressive clientele list should be doing. They've been communicating with their customers in order to better improve upon their services. A good example of this can be found in the latest PR referencing the Astrid360 technology solution which encompasses the healthcare industry but does provide features that also compliments their existing e-suite automated catalog. The addition of effective technological features that expand upon your already existing software platform either through SaaS or cloud based solutions is an excellent way to increase revenue flow significantly.
Earnings conference calls at the OTC level for the most part are non-existent. Conceivably one could be done but most choose not to. Webcasts throughout the year are more common which primarily highlight a company's future plans.
When the new calendar year begins one tends to develop more investor impatience when you have OTC stocks in your portfolio that put out 10K's instead of a fourth quarter 10Q. The additional two months you have to wait can seem more like a year due to the anticipation but the flip side is you only have to wait a month for the 1st Quarter 10Q after the 10K's release.
Looking forward to both financial reports since so many companies on the major exchanges reflected significant revenue increases for the fourth quarter which was a clear sign that many of the industries are starting to reflect a return to normalcy with a definitive reflection of recovery taking shape.
I really anticipate BYOC's financials to display some respectable revenue upside particularly when you factor in the five new contracts, two renewals as well as an extension (all listed below) they announced beginning on September 28th through November 2, of 2020. The new revenue stream probably wouldn't have been reflective in the 3rd quarter report but should be well represented in the 4th and 1st. What's also worth noting is what AUhills pointed out earlier today in his post regarding the positive references the company made in their 3rd Qtr report related to expectations going forward. It should all serve as a nice catalyst in terms stock price appreciation over the course of time.
Through our Service 800 Inc subsidiary, many of our clients; GE Healthcare, Audiology System, Inc 3M Healthcare, Johnson & Johnson Vision Care, Albany Molecular Research Inc., Sakura Finetek, Abbott Diagnostics, Biosense Webster, a Johnson & Johnson Company and Medtronic to name a few took the time during pandemic to begin strategic planning with Service 800 to grow their business with the company by renewals, expansion, and better ways to grow our programs with each and every one of them for the future. This select market segment continues to be a major source of revenue for the Company as we expand our services within this business segment. Renewals have been strong during the last three months and we anticipate revenue getting back in line with exceeding our expectations as we progress further into the year. All renewals that have taken place are on a minimum of a one to two-year term with an auto renewal taking place when the contract expires. During the pandemic, it made our customers realize the value that Service 800 brings to the clients in the form of providing valuable information to not only help their growth within their own companies, but it also helps them be better providers to their customers as well. We continue to look forward to growth into each division of these companies and expansion to exceed expectations that have been set. We value these customers and are looking for all of the positive growth we have set for the remainder of the year and moving onwards to future years to come.
Contract references mentioned in above paragraph:
September 28, 2020
Beyond Commerce's Service 800 Awarded Contract from Metrasens
Metrasens is the world's leading provider of advanced magnetic detection technologies. With a technology center and manufacturing facility in the United Kingdom, a North American sales and customer service hub in Chicago and a global network of distributors, the company's innovative products are designed to address deficiencies in conventional screening methods and make the world safer and more secure. Metrasens' mission is to take cutting-edge science from the laboratory and use it to create revolutionary, award-winning products that meet the distinct and diverse security needs of its customers. Metrasens' core technologies have a wide range of real-world applications, embodied by solutions that are easy to adopt and simple to use.
September 29, 2020
Beyond Commerce's Service 800 Awarded Contract from Compass Minerals
Compass Minerals is a leading provider of essential minerals focused on safely delivering where and when it matters to help solve nature's challenges for customers and communities. Its salt products help keep roadways safe during winter weather and are used in numerous other consumer, industrial and agricultural applications. Its plant nutrition business manufactures an innovative and diverse portfolio of products that improve the quality and yield of crops, while supporting sustainable agriculture. Additionally, its specialty chemical business serves the water treatment industry and other industrial processes. The company operates 21 production and packaging facilities with more than 3,000 personnel throughout the U.S., Canada, Brazil and the U.K.
October 1, 2020
Beyond Commerce's Service 800 Awarded Contract from Cargill
Cargill's 155,000 employees across 70 countries work relentlessly to achieve our purpose of nourishing the world in a safe, responsible and sustainable way. Every day, we connect farmers with markets, customers with ingredients, and people and animals with the food they need to thrive. We combine 155 years of experience with new technologies and insights to serve as a trusted partner for food, agriculture, financial and industrial customers in more than 125 countries. Side-by-side, we are building a stronger, sustainable future for agriculture.
October 5, 2020
Beyond Commerce's Service 800 Awarded Renewal Contract from GE
GE rises to the challenge of building a world that works. For more than 125 years, GE has invented the future of industry, and today the company's dedicated team, leading technology, and global reach and capabilities help the world work more efficiently, reliably, and safely. GE's people are diverse and dedicated, operating with the highest level of integrity and focus to fulfill GE's mission and deliver for its customers.
October 8, 2020
Beyond Commerce's Service 800 Awarded Renewal Contract from Steris
Steris is a leading provider of infection prevention and other procedural products and services. The company is focused primarily on healthcare, pharmaceutical and medical device Customers. Steris's mission is to help our customers create a healthier and safer world by providing innovative healthcare and life science product and service solutions around the globe. Founded as Innovative Medical Technologies in Ohio in 1985, the company was renamed Steris in 1987. However, some of the businesses that have been acquired and integrated into Steris, notably American Sterilizer Company, have much longer operating histories. We have approximately 13,000 associates worldwide and operate in more than 100 countries.
October 12, 2020
Beyond Commerce's Service 800 Awarded Contract from Vyaire Medical
Vyaire Medical's global workforce operates facilities around the world to manufacture and market more than 27,000 unique products for the diagnosis, treatment and monitoring of respiratory conditions in every stage of life.
Vyaire Medical Inc., a global company dedicated to respiratory care, enables, improves and extends lives with an unyielding focus on improving patient outcomes and increasing value for customers. The company consists of a conglomeration of well-known brands and was formed in October 2016 to serve healthcare providers with innovative devices and service solutions across the respiratory and anesthesia continuum of care. Headquartered in suburban Chicago, Vyaire's legacy brands have a 65-year track record of pioneering and advancing respiratory diagnostics, ventilation, and anesthesia delivery & monitoring. From original brands - including Bird, Bear, and JAEGER to industry leaders AirLife™, Vital Signs™, Viasys, and many others - Vyaire Medical is recognized, trusted and preferred by specialists in respiratory and anesthesiology healthcare worldwide.
October 15, 2020
Beyond Commerce's Service 800 Awarded Multi-Year Contract Extension from 3M
3M applies science in collaborative ways to improve lives daily.
Geordan Pursglove, Beyond Commerce's Chief Executive Officer, commented, "We look forward to continuing our work with a global company and industry leader like 3M. A multi-year contract extension demonstrates the value-add we provide in gathering actionable and quality customer feedback every day. Their trust in having us measure and improve their customer service is extremely important to us as we look to build long-term relationships."
November 2, 2020
Beyond Commerce's Service 800 Awarded Contract from Clarivate
Clarivate is a global leader in providing solutions to accelerate the lifecycle of innovation. Our bold mission is to help customers solve some of the world's most complex problems by providing actionable information and insights that reduce the time from new ideas to life-changing inventions in the areas of science and intellectual property. We help customers discover, protect and commercialize their inventions using our trusted subscription and technology-based solutions coupled with deep domain expertise.
Its customer base ranges universities, nonprofits, funding organizations, publishers, corporations, government organizations and law firms. Their trust in having us measure and improve their customer service is extremely important to us as we look to build long-term relationships.
I always appreciated your objectivity over on the CLWD board, my friend.
BYOC is just marking time at a higher low level of support until those market instruments of influence deem it's time for the next leg up. This particular OTC equity certainly has all the makings for a significant climb to higher levels.
Nothing wrong with getting the band back together again, my friend, with the intent of creating more share holder value.
Back on July 27th 2020 was when BYOC first announced the agreement to acquire E.G. Insights and at that time it was anticipated it would add approximately one million to the annual revenue total.
The real benefit has to do with the fact E.G. Insights over a thirty-year period has cultivated an impressive global clientele list which means their data analysis offerings are well respected and provides BYOC with a great opportunity to cross-sell offerings with their solutions and customers resulting in additional revenues moving forward.
The addition of Astrid360 is very important strategic move on BYOC’s part as far as customer/client confidence. One of the first questions a potential customer/client related to the healthcare industry is going to ask a company is if their resources are HIPAA compliant. Penalties related to non-compliance can be very severe and just one violation can put an entity out of business. Another advantage of Astrid360 is it serves a traditional on-premise platform as well as cloud-based software services.
Covid has transformed most industries some more than others and there’s always pockets of opportunity to be found that can assist a company in establishing measurable growth.
You obviously are not familiar with my presence on this board and for the majority who are, well they just got a good laugh from your previous post.
What buffers the need to criticize a company you've invested in (which truly amounts to nothing) goes back to the old adage that has stood the test of time.
"Buy low sell high"
Some are better at it than others
"we need objective substance."
In OTC land? Good luck trying to search for that particular quality.
If you're that emotionally distraught regarding OTC selections then I would suggest you direct your funds into less risky equities on the major exchanges where there truly is "objective substance" to be found.
"Am I missing the substance,"
That's always very subjective.
You could look at the last two PR's as a form of getting the word out to potential clientele and consequently leading to additional revenue flow.
Additional PR related to the Friday news story.
https://finance.yahoo.com/news/cloudcommerce-benefit-google-cookie-apocalypse-080100765.html
CloudCommerce to Benefit from the Google Cookie Apocalypse
More content below
CloudCommerce, Inc.
Tue, March 9, 2021, 12:01 AM
More content below
CLWD
+3.52%
The Company’s AI driven SWARM platform was designed from the very beginning to replace third-party web browser “cookies” with “personas” to protect user privacy and significantly reduce the cost of digital advertising
SAN ANTONIO, March 09, 2021 (GLOBE NEWSWIRE) -- CloudCommerce, Inc. (CLWD), a leading provider of digital advertising solutions, today announced that its AI-driven SWARM platform has completely replaced third-party web browser “cookies” with “personas” to protect user privacy and significantly reduce the cost of digital advertising. Doing so places the Company in a unique position to not only survive the “Cookie Apocalypse” unleashed by Google, but to profit from advertising industry chaos that is likely to follow.
Google’s recent announcement that it will restrict the use of third-party cookies is very close to a declaration of war against many ad-tech companies and major advertisers. "Today, we're making explicit that once third-party cookies are phased out, we will not build alternate identifiers to track individuals as they browse across the web, nor will we use them in our products," said David Temkin, Google's director of product management, ads privacy, and trust.
Andrew Van Noy, CloudCommerce CEO commented, “Google claims that it wants to promote user-privacy and digital consent through first-party data. However, some industry observers are skeptical. As in all wars, there will be winners and losers. The obvious winners will be those companies that mine first-party cookies or data. And, it is the big players, such as Google, Amazon, Facebook, Apple, and Microsoft which have the monopoly on first party data.”
This is cause for enormous concern within the advertising industry. The Google Cookie Apocalypse coming in 2022 could wipe out 85% of the digital market according to Data Science Analyst, Roger Kamena. Any data or ad-tech company that captures any information on unidentified users through a data management platform (DMP) is going to be in trouble.
Mr. Van Noy continued, “Our, AI driven SWARM platform was designed from the very beginning to replace web browser “cookies” with “personas” to protect user privacy and significantly reduce the cost of digital advertising. Is protecting user privacy important? Yes, absolutely. However, for more than a year now, our approach has actually reduced costs.
SWARM uses AI to manage “personas” which will now become more important than ever for targeting purposes. “Third-party cookies are dead,” concluded Mr. Van Noy. “We believe that we are on the right side of digital advertising history.”
For more information about AiAdvertising, please visit the Company’s new website at www.AiAdvertising.com.
About CloudCommerce
CloudCommerce is a leading provider of digital advertising solutions. Our flagship solution, SWARM, analyzes a robust mix of audience data to help businesses find who to talk to, what to say to them, and how to market to them. We do this by applying advanced data science, behavioral science, artificial intelligence, and market research techniques to discover, develop and create custom audiences for highly targeted digital marketing campaigns. For more information about the Company, please visit www.CloudCommerce.com.
Forward-Looking Statements
This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements are included in our filings with the Securities and Exchange Commission, including the “Risk Factors” section of our annual report on Form 10-K for the year ended December 31, 2019. Any forward-looking statement made by us in this release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
Press Contact:
CloudCommerce, Inc.
Tel: (800) 673-0927
communications@cloudcommerce.com
The confusion that stems in my mind is the result of the PR CLWD management released on February 23rd using the term "closed" regarding the "SPA" (Securities Purchase Agreement)".
The PR dated February 19th stated they had entered into a SPA with an institutional investor. I've never known a SPA to close that quickly but, I gave management the benefit of the doubt because you never know how long they've been negotiating with the entity prior to the initial announcement.
When the share price started dropping significantly as a mirroring of the overall market downward direction last Thursday which was substantially lower that the SPA agreed upon price I figured something was amiss. Normally, as you're witnessing today even with the overall market selling off significantly there's still a stabilizing quality reflected in the share price close to the agreed figure.
It's common in the anatomy of a Securities Purchase Agreement there's reference to a per share agreed upon price that is subject to adjustment in-between the date of the agreement up to the closing date.
What ultimately creates a more stable higher lows scenario in a share price is measurable revenue growth. CLWD will be no different when it comes to meaningful scrutiny by current and potential investors. In approximately 2 months we'll have the occasion to view not just one quarterly but two and will have the opportunity to evaluate a more significant DD area related to the company. We all know 3rd Qtr revenues came in at 2.4M and that serves as a starting point in my assessment and I will be expecting incremental growth from here on out with what I hope will be real quantifiable organic revenue growth numbers starting to be reflected in the second half of 2021. Also, it's worth keeping in mind when factoring in current TTM revenue and O/S count we're still trading at a multiple of only (5). Way undervalued.
One of the biggest attributes in becoming a successful software enterprise within the industry you serve is the foresight to recognize a viable future direction and developing a proprietary product accomplishing this directive.
Collecting data through third party cookies or user tracking identifiers through E-mail is becoming antiquated. Trade Desk over the last few years has anticipated the phasing out of third party cookies and consequently has chose the direction of Unified ID which is E-mail based which Google addressed in one of its latest PR's and also quoted in CLWD's most recent PR: "Further, Mr. Temkin, Google's Director suggested that workarounds such as user tracking by email addresses will eventually fail as users demand tighter browsing privacy under an evolving regulatory."
The CLWD PR says it all in that they have developed an effective way to circumvent this issue and a more precise method of isolating a target audience and it's through Personas created through Artificial Intelligence and Machine Learning.
Where the intrigue lies has to do with the initial evolution of the SWARM platform with the development of the advanced data and behavioral sciences characteristics. Early on there were indications of a high success rate in accomplishing client goals. The sophistication and effectiveness was becoming evident and the additional layers of Artificial Intelligence through the implementation of Predict89 and WRENCH.AI into the SWARM "proprietary" tech stack has enhanced their product/services to new successful levels of refinement.
Coming up with new "alternative targeting technology" isn't achieved overnight even for a prominent player with loads of capital within the space such as Trade Desk. The involved process of developing a different solution holding up to the test of time with efficient/well written maintainable code is no easy task and I'm afraid the remedy isn't going to be found in quick fix form.
But, guess what... CLWD/AiAdvertising Inc. already has an effective solution.
No doubt. Just consider this much about CLWD's possibilities... that no matter where the MM's decide to take the share price in the immediate term the only time current/future share holders will miss out on maximum profits will be the day they decide to sell and I'm not talking about just 2021 I'm talking about many years to come. This is that once in a lifetime stock.
Companies like "The Trade Desk" in order to maintain and gain market share within the digital advertising industry rely heavily on third party cookies and Unified ID's collected from user's email accounts in order to remain competitive with the major players on the block. Google is using its stature of power/influence by better positioning itself with the phasing out of third party cookies and heavy regulatory attention being directed at Unified ID accessibility all in the name of more consumer privacy.
The real intrigue in all this has to do with the fact CLWD now has a legitimate solution to the obstacles Google/Apple have created for those companies like The Trade Desk, Magnite, Criteo, etc.
"MM's still don't want to give it up"
In the process of trying to fill a large institutional order most always is the case in these types of instances.
I have to admit this is the most substantive PR they've ever released in my nine months of being invested in the company. Like I've said my primary decision to take a position has always been about the technology based on its sophistication and how it can transform the industry it serves.
That Thursday afternoon PR CLWD puts out on occasion would be a nice addition to today's activities.
You won't regret your decision, my friend.
Excellent comparison, my friend. Kind of feels like October 12th 2020 all over again. LOL.
Excellent interpretation of what is playing out by Aussiekevin and Rawsteel reflected in posts #26824 and 26825.
Company fundamentals haven't changed since prior to the spike back on January 6th, in fact, they've improved since then considering the raising of capital has been achieved. The future prospects of their business model and plan is still very promising.
The March effect. History of the markets reflect this time of the year being most negative. The last three quarters of the year of 2020 was exceptional for the markets. This sell off was in the works well before it happened and financial institutions were charting out their short positions well in advance. The investment news wires using the dramatic rise in the 5 & 10-year Treasury note yields are just camouflage. There's always a flip side to the old saying "a rising tide lifts all boats" and we're seeing it play out in the immediate. Once the correction has happened and the financial institutions start rotating out of their short positions positive news will start flowing again being directed towards the stimulus package. With 4th quarter earnings being so exceptional and the overall economy showing signs of a solid rebound, it will be a quick turn around for the markets. Patience is the key and always will be to amassing wealth in the markets.
Yes indeed, the day-in/day-out monitoring of an investment portfolio. The ultimate psychological roller-coaster ride.
The long drawn out repetition game of drop and recover so well orchestrated by the "Deep Pocket Investors" (Financial Institutions) to the point of mental exhaustion by the small, impatient retail investor to the extent of letting go of the coat tails way to early and missing out on the significant moves to the upside.
CLWD for instance:
Dead in the water for most of 2020 until June PR's when it hits an intraday high of .0163 for the first time on July 6th.
Trends lower until the 2nd Quarter 10Q is about to be released and as result hits an intraday high of .0163 for the second time on August 10th.
From August 11th to January 5th on average it stays in the .0060-.0070 range with the occasional head-fake off of a PR and 3rd Quarter 10Q that periodically takes it to the .01 cent range.
Then we get to that magical January 6th date when the "Whales" had accumulated enough from the little guy over the preceding six months and decided it was time to take it higher.
So far since January 6th we've had two intraday highs--one on January 15th--.1830 and the other on February 10th--.1850.
I would anticipate some decent catalysts in the not too distant future with some PR's in March followed by the 10K in April and the 1st Quarter 10Q in May. That's when the share price movement should really get interesting.
It should be well worth the wait.
You know I wish you only the best when it comes to your individual investments, my friend.
Thank you.
When making comparisons to other equities whether it be those listed on major exchanges (more conservative metrics) or the OTC markets (no metrics what-so-ever), it's very evident CLWD is still way undervalued.
CLWD share price of .08 times an O/S total of 915,073,664 equals a Market Cap of 73,205,893 divided by a TTM (trailing-twelve-month) revenue total of 10.39M equates to a price-to-sales ratio of (7).
You can't even come across this type of value on major exchanges take the leader in the space for instance Trade Desk which trades on the Nasdaq they have a current price-to-sales ratio of (41) and as far as the OTC goes the majority of the equities have TTM revenues of less than a million if any at all and have price-to-sales multiples in triple digits.
One of the market trends playing out over the last few months has been the money flow into penny stocks. Everyone has heard the aphorism ("A rising tide lifts all boats"), well that's what is transpiring in OTC land and I expect the trend to continue well into 2021. When you factor in new influences having major effects whether it be "Wall Street Bets" or "Stimulus Checks" it all comes down to directed money flow. Ultimately, that is the main driving force behind any ascending share price.
Those stocks such as CLWD being so well position in terms of value will be more prone to parabolic movements to the upside.
Hey Lakota-45,
Good to get a response from some of the previous long term CLWD holders.
I know you're no longer invested in CLWD but I do see you're still a moderator for the board. A few current investors expressed the desire for post #26686 to be stickied. I would appreciate you taking the steps to accomplish this request.
Oh, and as far as WDLF goes... TTM revenues of 517,000 and O/S count of 7.4 billion reflecting a 152M market cap equating to a 294 price-to-sales ratio is all the transparency I need to see. No thanks.
Nice to get a post from you, my friend.
"Hope they really kick it into gear beyond name changes."
What they've managed to accomplish over the last couple months has really put them in better position to accomplish that objective.
If you go to page 5 of this link displaying the 424B5 filing it will give you a close approximate number of what the updated total of the O/S figure will be: "Common stock to be outstanding after the offering"
https://www.otcmarkets.com/filing/conv_pdf?id=14731874&guid=j4NaUnf_5YSqxth
CLWD management always registers disclosures with the SEC providing such information. This case is no different as I point out in post #26705.
One of the qualities I appreciate the most about this company is they're very transparent which is very rare for an OTC company.
Trying to add couple million today, but looks like the real cheapies are gone.
To think an investor would react to a low volume premarket print is just the realities of the OTC markets. There'll always be a percentage of investors who gamble with funds that are earmarked for next months living expenses. Those investors are susceptible to early opening market head fakes. Fundamentally nothing has changed regarding the company. A low volume Friday coupled with yesterdays "sky is falling" overall market reaction should make for an interesting dynamic early, particularly if the MM's decide to get real creative with their own personal inventories of this equity.
Allen,
If you go to page 5 of this link displaying the 424B5 filing it will give you a close approximate number of what the updated total of the O/S figure will be: "Common stock to be outstanding after the offering"
https://www.otcmarkets.com/filing/conv_pdf?id=14731874&guid=os7aUn6vbVlhT3h
An aspect that should be pointed out in regard to the securities purchase agreement scheduled to close tomorrow is in relation to the vetting process by the institutional investor. The procedure is very involved and thorough before committing to the agreement and the financial instruments being reviewed regarding feasibility and/or risk potential were well examined which would have included latest revenue numbers. Leads one to believe the 4th quarter revenue figures should reflect solid growth.
Closing in on an eight hundred percent gain on my long term hold over the last eleven months. Well worth it.
GENERAL OVERVIEW OF CLWD:
FINANCIALS:
Over the last three years (2017-2019) CLWD’s 4th quarter financials were reflected in their 10K (full year ending report). A company of CLWD’s standing has a 90-day period after the end of the fiscal year to submit the 10K disclosure. Consequently, like the last three years have consistently presented the numbers should be released in early April.
REVENUES:
Over the first three quarters of 2020 CLWD has amassed revenues totaling $8,019,804 (1st Qtr--$3,204,407, 2nd Qtr--$2,412,221, 3rd Qtr--$2,403,176). In a PR released on June 16th 2020 CLWD management stated they anticipated revenues to exceed 14M for the year. Unfortunately, due to the effects of covid on the overall economy in 2020 it’s not likely they’ll hit their projection. What’s worth pointing out is the fact CLWD’s financials reflected an increase in revenue for each of the first three quarters of the 2020 fiscal year when compared to 2019 (1st Qtr up 21%, 2nd Qtr up 12% & 3rd Qtr up 16%). Which is very impressive and really constitutes the effectiveness of their product/services and I should add this is prior to AI being integrated with the proprietary SWARM software applications. What’s really noteworthy is when the country went into lockdown during the second quarter for several weeks. So many companies large and small reported lower revenues for the quarter when compared to the previous year. I’m sure the dominant player in the space (Trade Desk—price to sales ratio of 55) would have welcomed an increase of 12% for the 2nd quarter like (CLWD—price to sales ratio of 7) instead of their 13% decrease from the previous year’s quarter.
TECHNOLOGY:
SWARM is still in its infancy having been released a couple years ago. The uniqueness of the product centers around the incorporation of behavioral analytics with the results enabling them to attract more higher-margin enterprise clients over the course of that time. The effectiveness of the product showed as companies cut back spending over the course of 2020 and yet CLWD was still able to exceed revenues for the previous year and keep in mind this is prior to AI layers being added to the tech stack.
It’s very apparent the licensing agreements with Pattern89 & Wrench.AI allowing CLWD to integrate “Artificial Intelligence Technology” into their entire proprietary SWARM software application tech-stack has taken the company to that next level of recognition based on a product now that has no limitations as to how the service can benefit a company wanting to maximize the efficiency of their marketing/advertising dollars. The results they’ve made public displaying the effectiveness of their services through their aiAdvertising venture is starting to get a lot of attention and should open up some incredible avenues for them resulting in significant future growth.
What we’ve been able to glean so far from PR releases has confirmed the AI services have been available for at least six months--(”After six months, the client increased its commitment by 340%”). They’re still in the developmental stage of transitioning SWARM into a cloud hosted software platform--(“The company is developing SWARM into a cloud hosted software platform that will harness the power of artificial intelligence, machine learning, and predictive algorithms to eliminate the inefficiencies, waste and guesswork that is inherent and accepted in today’s data driven digital marketing campaigns"). When they accomplish this, I would anticipate a significant jump in revenue stream as they transition from their past cumbersome hourly/monthly charge model of fixed or variable implementation fees to a more streamline recurring self-service subscription revenue model the cloud hosted software platform would provide.
FUNDING:
Having a background in the software industry I can attest to the various degrees of difficulty which are encountered with various phases of development. Temporary hurdles have a tendency to present themselves and complicate the process. That’s why taking necessary steps in making sure they’re able to meet the financial demands as they transition moving forward by raising additional capital in a more non-toxic way is very important. The reality is, even though CLWD generates revenue, it still falls into the category like every other OTC company of not generating enough cash to make capital expenditures via profits to grow the company. The Direct Offering is an excellent avenue and accomplishment at this stage of the company’s development and as llcoolm11, Alfy1952, Rawsteel, Marinokv, Zuper8, Tincups & Hbhmb all pointed out, in a constructive fashion, is very favorable in many ways.
I can’t help but reflect back to a message one of the CLWD message board members posted a few months back regarding a response he received from the CLWD CFO—Mr. Greg Boden concerning the PR referencing the up-listing to the OTCQB. Essentially the response stated that when the company publicly announces the intent of accomplishing an objective the plan to get there is already in the process of being initiated. So, with that being said... I’m looking forward to the initiation of the orchestrated plan over the coming months (maybe the posting of a better-than-expected revenue number for a quarter? or the signing of a big client? Who knows?) that will be timed with the S-3 in mind creating upward pressure on the CLWD share price by potential and current investors in order to maximize the amount of working capital raised. 2021 is going to be a blast.
Par value is the value of a single common share as set by a corporation's charter. It is not related to the actual value of the shares.
Anyway, if you take another look the par value is .0010.
Well Lakota-45... at least they have a TTM revenue total of 10.39M. A bit more stable than say the likes of $wdlf$ or $inqd$ which have no revenues to speak of, wouldn't you say?
Throughout my investment history I've rarely invested in OTC stocks. Prior to finding CLWD I flipped a couple but I find that mode way to consuming particularly at this point in my life. Don't get me wrong, I'm not that old but over a thirty year investment career I've been able to establish a well balanced comprehensive portfolio amassing enough wealth to put me in the position of not having to monitor activity on a consistent basis and I really have an appreciation for the flexibility that provides.
The reason I took such a large position in CLWD has to do with the companies fundamentals. Financials are as good as you're going to find in OTC land; a better than most share structure; not only actual revenues but respectable revenue numbers; solid clientele list and above all the specialized features of their "PRODUCT" and the infinite growth prospects of the industry it which it serves.
Now to your question: when it comes to public companies the degree of revenue growth trumps everything. It's quite simple. If you're a company that has significant revenue growth quarter after quarter investor momentum will always keep a share price ascending even through a reverse split. The flip side of course being your typical OTC company that has no viable product or revenues to speak of and only has intent on riding the dilution wave until it's at the point of doing a reverse split and starting the process all over again. Naturally, the reverse split will play out and the share price will plummet.
I anticipate the incorporation of AI into SWARM having a major impact on revenue growth going forward. If this starts playing out over the next couple years I feel the O/S count will still be reasonable enough to where the share price may reach the Nasdaq qualifying standard on its own. Price to sales multiples are really high in today's markets so they're not scrutinized as much when it comes to traditional measurements. Now you have analysts justifying a share price based on revenue numbers 1 to 2 years down the road instead of a couple quarters. Metrics have changed considerably and when you factor in CLWD providing services to trillion dollar industries such a digital advertising/marketing and AI, well you get the picture and its all good.
I find nothing floating around cyberspace confirming he's an employee. His connection to CLWD in the past was between 2015-2017. When CLWD acquired Indaba Group and as a result he served as a CloudCommerce Board Member through 2017.
The important point being made involves his recent acquirement of shares to take him over the 5% criteria. Law requires passive investors to file within 10 days of acquiring 5% or more of a security.